Highlights
NASDAQ: GLYC       Glycomimetics Inc
Last Price Today's Change   Day's Range   Trading Volume
3.23   +0.01 (0.31%)  3.16 - 3.33  439,400

Overview

 
Avg Volume (4 weeks):268,395
4 Weeks Range:3.06 - 3.62
4 Weeks Price Volatility (%):
30.36%
52 Weeks Range:1.82 - 6.72
52 Weeks Price Volatility (%):
28.78%
Average Price Target: 14.00
Price Target Upside/Downside: +10.77

Headlines



No recent Headlines for this stock.


Business Background

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22